Corbion N.V. (AMS:CRBN)
Netherlands · Delayed Price · Currency is EUR 20.06
+0.09 (0.45%)
Aug 7, 2026, 4:39 PM CET
Corbion Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,253 | 1,267 | 1,288 | 1,264 | 1,458 | 1,071 |
Revenue Growth | -1.14% | -1.61% | 1.90% | -13.29% | 36.15% | 8.54% |
Gross Profit Gross Profit Growth | 309.5 | 330.3 | 312.1 | 305.4 | 324.3 | 265.8 |
Operating Income Operating Income Growth | 95.1 | 116.5 | 77.3 | 77.3 | 110.8 | 82 |
Net Income Net Income Growth | 32.4 | 74.8 | 192.2 | 72.9 | 90 | 78.3 |
Earnings Per Share EPS Growth | 0.56 | 1.27 | 3.24 | 1.22 | 1.51 | 1.32 |
EPS Growth | -55.92% | -60.80% | 165.57% | -19.20% | 14.39% | 7.32% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Functional Ingredients & Solutions Functional Ingredients & Solutions Growth | 965.6 | 970.4 | 997.9 | 1,019 |
Health & Nutrition Health & Nutrition Growth | 287.3 | 297 | 290.2 | 245.4 |
Total Total Growth | 1,253 | 1,267 | 1,288 | 1,264 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 36 | 44.7 | 49.3 | 70.2 | 58.2 | 42.2 |
Total Debt Total Debt Growth | 517.6 | 446.6 | 509.2 | 785.5 | 759.2 | 503.2 |
Net Cash (Debt) Net Cash Growth | -481.6 | -401.9 | -459.9 | -715.3 | -701 | -461 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -8.32 | -6.82 | -7.76 | -11.98 | -11.78 | -7.76 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 144.2 | 160.9 | 184.1 | 165.4 | 39 | 22.4 |
Capital Expenditures CapEx Growth | -68.6 | -68.2 | -84.2 | -149.3 | -235.8 | -148.7 |
Free Cash Flow Free Cash Flow Growth | 75.6 | 92.7 | 99.9 | 16.1 | -196.8 | -126.3 |
Free Cash Flow Growth | -18.45% | -7.21% | 520.50% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 24.70% | 26.06% | 24.23% | 24.16% | 22.24% | 24.82% |
Operating Margin | 7.59% | 9.19% | 6.00% | 6.12% | 7.60% | 7.66% |
Pretax Margin | 6.41% | 7.49% | 4.85% | 3.59% | 7.98% | 8.08% |
Profit Margin | 2.59% | 5.90% | 3.56% | 3.41% | 6.17% | 7.31% |
FCF Margin | 6.03% | 7.31% | 7.76% | 1.27% | -13.50% | -11.79% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.640 | 0.640 | 0.640 | 0.610 | 0.560 | 0.560 |
Dividend Per Share Growth | 56.25% | 0% | 4.92% | 8.93% | 0% | 0% |
Dividend Yield | 3.20% | 3.45% | 3.32% | 2.89% | 1.76% | 1.35% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.84 | 14.62 | 6.67 | 15.89 | 21.09 | 31.39 |
Forward PE | 14.04 | 13.11 | 16.12 | 16.73 | 19.33 | 28.99 |
P/FCF Ratio | 15.23 | 11.54 | 12.57 | 71.13 | - | - |
PS Ratio | 0.92 | 0.84 | 0.97 | 0.91 | 1.29 | 2.28 |